Proven Checks Buyers Miss In A Batch Manufacturing Record
The first commercial batch from a new intermediate supplier is not a formality. Here is the checklist, the five approval outcomes, and how to log the call.
Canagliflozin Intermediate;2-(4-fluorophenyl)-5-[(5-bromo-2-methylphenyl)methyl]thiophene; 2-(2-methyl-5-bromobenzyl)-5-(4-fluorophenyl)thiophene; 2-[(5-bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)thiophene
CAS: 1030825-20-7
Chemical Formula: C₁₈H₁₄BrFS
Molecular Weight: 361.27
Availability: R&D; Commercialization
⬤ CAS No.1030825-20-7
⬤ Our Packaging type:
20kg barrel;5kg barrel;1kg bag;500g bag ; Customized Packaging
| Product Name | 2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene |
| CAS.No | 1030825-20-7 |
| Molecular Formula | C₁₈H₁₄BrFS |
| Molecular Weight | 361.27 |
| Related Categories | Canagliflozin intermediates |
| Appearance | Light yellow to white powder |
| Density | 1.388 |
| Melting Point | 103 °C |
| Boiling Point | 438.3±40.0 °C(Predicted) |
| Storage Conditions | Keep in dark place,Sealed in dry,Room Temperature |
| Solubility | Soluble in DMSO (slightly warmed), hexane (slightly warmed) |
| Form | solid |
| Chemical properties | The compound has a thiophene ring structure, as well as brominated and fluorinated substituents, which give it unique reactivity in organic synthesis. |
| Application | Canagliflozin intermediates, a raw material for the treatment of type 2 diabetes in adult patients. |
Reliable Global Partner
“Tianming Pharmaceutical has redefined reliability for us. Their ability to deliver high-potency APIs and intermediates under tight deadlines—is unmatched. The team’s transparency in documentation and proactive updates make them a stress-free partner. A true backbone for our operations!”
March 18, 2024
Outstanding Technical Guidance
“Few suppliers align so perfectly with EU GMP requirements. Tianming’s commitment to audit-ready quality systems, batch traceability, and purity consistency has streamlined our production processes. Their diligence eliminates regulatory risks—a rare advantage in today’s market.”
February 15, 2024
Beyond Supplier, A Solutions Partner
“Tianming’s technical team doesn’t just deliver materials—they solve problems. When we faced stability challenges with a niche compound, their scientists proposed a tailored purity adjustment that saved our project timeline. Their agility transforms obstacles into opportunities.”
June 15, 2024
Strategic Growth Ally
“Over 5+ years, Tianming has consistently adapted to our evolving needs—whether scaling volumes or supporting custom synthesis projects. Their ethical pricing models and long-term vision make them more than a vendor; they’re integral to our competitive edge.”
April 27, 2024
The first commercial batch from a new intermediate supplier is not a formality. Here is the checklist, the five approval outcomes, and how to log the call.
The first commercial batch from a new intermediate supplier is not a formality. Here is the checklist, the five approval outcomes, and how to log the call.
A buyer-side decision tree for handling an intermediate supplier change notice — what to accept, contest, or reject, and how to log the call.
Manufacturer and supplier of pharmaceutical APIs and intermediates. Contact us for technical support and sourcing solutions.